Insecticides India reported strong set of numbers in Q3FY23 led by (1) 53% growth in B2C sales and 30% higher revenues of Maharatna products, (2) higher B2C sales and Maharatna revenues led to gross and EBITDA margin expansion of 40bps and 60bps, respectively YoY and (3) the company is on track to commence the new production units at Rajasthan and Gujarat in Q4FY23.